Review: could Multiple sclerosis cause Bipolar disorder?
We study 203,337 people who have Multiple sclerosis from FDA and social media. Among them, 403 have Bipolar disorder. Find out below who they are, other conditions they have and drugs they take.
Get a free personalized report of your drugs: we study for you 352 million drug outcomes from FDA and social media. Start to use eHealthMe >>>
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) (latest reports from 279,818 patients) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen, Betaseron.
Bipolar Disorder (mood disorder) (latest reports from 79,751 patients) has been reported by people with depression, quit smoking, multiple sclerosis, stress and anxiety, pain.
On Sep, 18, 2014: 203,337 people who have multiple sclerosis are studied. Among them, 403 (0.20%) have Bipolar Disorder.
Gender of people who have multiple sclerosis and experienced Bipolar disorder * :
|Bipolar disorder||78.17%||21.83% |
Age of people who have multiple sclerosis and experienced Bipolar disorder * :
|Bipolar disorder||0.00%||0.00%||2.55%||10.97%||26.28%||30.10%||22.19%||8.16% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Depression (18 people, 4.47%)
- Pain (9 people, 2.23%)
- Anxiety (7 people, 1.74%)
- Affective disorder (5 people, 1.24%)
- Multiple sclerosis relapse (4 people, 0.99%)
- Smoking cessation therapy (4 people, 0.99%)
- Attention deficit/hyperactivity disorder (3 people, 0.74%)
- Prophylaxis (3 people, 0.74%)
- Convulsion (3 people, 0.74%)
- Hypertension (2 people, 0.50%)
Most common drugs used by these people * :
- Avonex (229 people, 56.82%)
- Tysabri (110 people, 27.30%)
- Rebif (97 people, 24.07%)
- Betaseron (23 people, 5.71%)
- Depakote (17 people, 4.22%)
- Lithium carbonate (14 people, 3.47%)
- Klonopin (13 people, 3.23%)
- Flexeril (13 people, 3.23%)
- Prozac (11 people, 2.73%)
- Zyprexa (11 people, 2.73%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Multiple Sclerosis and Bipolar Disorder?
Get connected! Join a mobile support group:
- group for people who have Bipolar Disorder and Multiple sclerosis
- group for people who have Multiple sclerosis
- group for people who have Bipolar Disorder
Comments from related studies:
From this study (5 days ago):
Doc called and said I had low potabssium
From this study (1 month ago):
I lived in a condominium where each of my neighbors smoked and after I began taking Tecfidera I developed a strong sensitivity to this. Other than myself, no one else could sense the smoke. I became so sensitive that I could tell when a neighbor would start and stop smoking. I then developed constant chest pains and tightness in my breathing. Is it possible that I'm highly sensitive because Tecfidera controls MS by decreasing the activity of one's immune system? Does this naturally increase ones vulnerability to the effects of things like second and third hand smoke?
From this study (1 month ago):
brain and spine MRI showed lesions in my brain, C1-C-4. L3-L6
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Multiple sclerosis, Bipolar disorder
You may be interested at these reviews (what is this?):
- Lexapro and memory loss
I actually have no idea what other medicine I was on the week I took Lexapro, it was back at the end of February 2014 right before I checked myself into the psych hospital. I formed no memory for a whole week just because of one drug! My friends and family tell me what happened that week and I have ...
- How saphris causedmy husbands death
My husband was given saphris to treat bipolar disorder in June, 2010. After taking it for two weeks,the dosage was increased. On July 29, 2010, he started having hallucinations and before I could get help (we lived in rural area), he committed suicide.
- Developed systemic scleroderma while on copaxone for 10 yrs.
I just tested positive for both crest and systemic scleroderma. I already have ms and have been on copaxone over 10 yrs. I believe copaxone may have caused this. I dont blame the makers. I am sure it has helped more then hurt, but I wonder if this has happened to others. If so it should be something ...
More reviews for: Multiple sclerosis, Bipolar disorder
Common treatments for Multiple Sclerosis and their efficacy:
Could your drug cause it?
Studies of common Multiple sclerosis symptoms:
- Exhaustion in Multiple sclerosis (18,937 reports)
- Multiple Sclerosis Relapse in Multiple sclerosis (18,620 reports)
- Lack Of Strength, Muscle Weakness, Weakness in Multiple sclerosis (14,531 reports)
- Fall in Multiple sclerosis (14,113 reports)
- Pain - Head in Multiple sclerosis (11,323 reports)
- Ms in Multiple sclerosis (11,317 reports)
- Cystitis in Multiple sclerosis (10,152 reports)
- Gait Disturbance in Multiple sclerosis (9,515 reports)
- Influenza Like Illness in Multiple sclerosis (8,694 reports)
- Pain Relief By Acupuncture in Multiple sclerosis (7,894 reports)
Bipolar Disorder related symptom studies:
Multiple Sclerosis is also known as: MS.
Bipolar Disorder is also known as: Bi-polar, Bipolar.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.